Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 17/11/20141 min de lectura
Smith Miller and Patch, Inc. et al.; Withdrawal of Approval of 14 New Drug Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of 14 new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →